Postmenopausal endometrial carcinoma presenting as urinary incontinence: a case report

Priti Agrawal; Rishi Agrawal; Jaswant Jain; Anandi Lobo

doi:10.18203/2320-1770.ijrcog20212215

Authors

Priti Agrawal Department of Obstetrics, Gynecology and Infertility, Aarogya Hospital and Test Tube Baby Center, Raipur, India http://orcid.org/0000-0003-3969-8592
Rishi Agrawal Department of General and Laparoscopic Surgery, Aarogya Hospital and Test Tube Baby Center, Raipur, India
Jaswant Jain Department of General Surgery, Raipur Institute of Medical Sciences, Raipur, India
Anandi Lobo Department of Pathology, Aarogya Hospital and Test Tube Baby Center, Raipur, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20212215

Keywords:

Postmenopausal bleeding, Endometrial carcinoma, Hydrometra, Gynecological malignancy

Abstract

Endometrial carcinoma (EC) most commonly presents with postmenopausal bleeding (PMB) or blood tinged vaginal discharge. Watery vaginal discharge is usually reported in fallopian tube malignancy. We reported a case of EC where she had profuse watery discharge from private part mimicking urine and so patient visited urologist for urinary incontinence and was later diagnosed as endometroid adenocarcinoma. A 73 year old female presented with history of passing urine involuntarily for last 3 months. Endometrial biopsy revealed endometrial endometroid adenocarcinoma-FIGO grade-2. FDG PET-CT scan revealed primary neoplastic pathology of uterus or endometrium with no lymphadenopathy. PMB or vaginal discharge in women with high risk factors like obesity, diabetes mellitus, unopposed oestrogen exposure needs prompt evaluation. PMB is highly suspicious of malignancy arising from cervix or uterus but copious watery discharge should also be evaluated thoroughly with ultrasound and confirmation of underlying malignancy with hysteroscopic guided endometrial sampling should be done.

Metrics

Metrics Loading ...

References

WHO. Fact sheet: GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accepted on 8 March 2021.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.

Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, et al. Endometrial cancer associated symptoms: a case-control study. J Wom Health. 2016;25(11):1187-92.

Smith PP, O’Connor S, Gupta J, Clark TJ. Recurrent postmenopausal bleeding: a prospective cohort study. J Minim Invasive Gynecol. 2014;21(5):799-803.

Balasubramaniam K, Ravin P, Larsen PV, Sondergaard J, Jarbol DE. Specific and unspecific gynecolgoical alarm symptoms-prevalance estimates in different age groups: a population-based study. Acta Obstet Gynecol Scand. 2014;94(2):191-7.

Ker CR, Jeng CJ. Endometrial adenocarcinoma initially mistaken as urinary incontinence. Taiwanese J Obstet Gynecol. 2020;59(4):590-3.

Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer diagnosis, treatment and follow-up. Annals Oncol. 2016;27(1):16-41.

Hanegem NV, Prins MMC, Bongers MY, Opmeer BC, Sahota DS, Mol BWJ, et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynocol Reprod Biol. 2016;197:147-55.

Koh W, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170-99.

Chaudhry S, Hussain R, Zuberi MM, Zaidi Z. Rare primary fallopian tube carcinoma; a gynecologist’s dilemma. J Pakistan Med Assoc. 2016;66(1):107-10.